BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15197999)

  • 1. [Arthritis following intravesical instillation of BCG for urothelial cancers].
    Minei S; Irie A; Chen W; Kurosaka S; Tabata K; Koh H; Ishii D; Iwamura M; Uchida T; Shimura S; Baba S
    Nihon Hinyokika Gakkai Zasshi; 2004 May; 95(4):657-62. PubMed ID: 15197999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations.
    Ng KL; Chua CB
    Asian J Surg; 2017 Apr; 40(2):163-165. PubMed ID: 25183290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reactive Arthritis during the Second Course of Intravesical BCG Therapy Requiring Administration of Methotrexate : A Case Report].
    Ikeuchi R; Sunada T; Yoshikawa T; Yoshida T; Tabuchi Y; Kajita Y; Segawa T
    Hinyokika Kiyo; 2017 Aug; 63(8):329-332. PubMed ID: 28889718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reiter's syndrome following intravesical instillation of Bacillus Calmette-Guerin].
    Okamoto K; Hamano T; Kawaguchi T
    Hinyokika Kiyo; 2010 Feb; 56(2):111-3. PubMed ID: 20185998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravesical Bacillus Calmette-Guerin (BCG: Tokyo 172 strain) instillation for carcinoma in situ of the bladder: results with 6 successive instillations of 40 mg BCG].
    Mugiya S; Nagata M; Takayama T; Ozono S; Ito T; Maruyama S; Hadano S; Nagae H
    Hinyokika Kiyo; 2004 Jul; 50(7):469-73. PubMed ID: 15334890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.
    Miyake H; Eto H; Hara S; Okada H; Kamidono S; Hara I
    Int J Urol; 2002 Dec; 9(12):677-80. PubMed ID: 12492951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polyarthritis in 4 patients treated with intravesical BCG-therapy for carcinoma of the bladder].
    Belmatoug N; Levy-Djebbour S; Appelboom T; De Gennes C; Peltier AP; Meyer O; Kahn MF; Carbon C
    Rev Rhum Ed Fr; 1993 Feb; 60(2):162-6. PubMed ID: 8136810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
    Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
    Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin.
    Dinney CP; Greenberg RE; Steinberg GD
    Urol Oncol; 2013 Nov; 31(8):1635-42. PubMed ID: 22575238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.
    Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE
    Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
    Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical bacillus Calmette-Guèrin for the treatment of superficial bladder cancer in renal transplant patients.
    Palou J; Angerri O; Segarra J; Caparrós J; Guirado L; Diaz JM; Salvador-Bayarri J; Villavicencio-Mavrich H
    Transplantation; 2003 Nov; 76(10):1514-6. PubMed ID: 14657696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.
    Koga H; Kuroda M; Kudo S; Yamaguchi A; Usami M; Suzuki T; Naito S
    Int J Urol; 2005 Feb; 12(2):145-51. PubMed ID: 15733108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
    Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder.
    Watanabe E; Matsuyama H; Matsuda K; Ohmi C; Tei Y; Yoshihiro S; Ohmoto Y; Naito K
    Cancer Immunol Immunother; 2003 Aug; 52(8):481-6. PubMed ID: 12707736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of a low-dose intravesical bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder: results after six successive instillations of 40 mg BCG.
    Mugiya S; Ozono S; Nagata M; Takayama T; Ito T; Maruyama S; Hadano S; Nagae H
    Jpn J Clin Oncol; 2005 Jul; 35(7):395-9. PubMed ID: 15976065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
    Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A
    Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophagocytic syndrome after intravesical bacille Calmette-Guérin instillation.
    Misra S; Gupta A; Symes A; Duncan J
    Scand J Urol; 2014 Jun; 48(3):328-30. PubMed ID: 24070063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.